Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,326,680
+$452,115 QoQ
Shares Held
13,220
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
#1,573
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $10,204,212 across 14 Drug Manufacturers - General names. ABBV ranks #1 (32.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
13,220 | $3,326,680 | |
| 2 | JNJ |
Johnson & Johnson
|
8,020 | $2,036,839 | |
| 3 | AMGN |
Amgen Inc
|
3,675 | $1,330,791 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
8,055 | $1,017,668 | |
| 5 | LLY |
ELI LILLY & Co
|
641 | $768,834 | |
| 6 | NVO |
Novo Nordisk A S
|
11,256 | $539,612 | |
| 7 | PFE |
Pfizer Inc
|
18,621 | $448,393 | |
| 8 | NVS |
Novartis AG
|
1,774 | $278,021 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,326,680 | 13,220 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,874,565 | 13,217 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,019,266 | 13,214 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $3,063,274 | 13,230 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,438,675 | 13,138 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,752,045 | 13,135 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $2,333,556 | 13,132 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,410,638 | 12,207 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,093,230 | 12,204 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,221,802 | 12,201 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,891,563 | 12,206 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,822,556 | 12,227 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $1,632,388 | 12,116 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $1,927,898 | 12,097 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $1,984,570 | 12,280 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $1,647,830 | 12,278 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $1,860,740 | 12,149 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $1,995,249 | 12,308 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $1,629,268 | 12,033 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $1,297,999 | 12,033 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $1,344,921 | 11,940 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $11,940 | 1,292,147 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $1,122,181 | 10,473 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $881,593 | 10,065 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $988,083 | 10,064 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $763,880 | 10,026 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||